. (A) Fluorescent spectra of 10 (7.2 M) observed after 10 min of incubation with WT-TTR (3.6 M, blue trace) and alone in phosphate buffer (red trace). Excitation spectrum is presented as a dotted black trace. Recombinant WT-TTR (3.6 M, tetramer) was incubated with (B) 5 or (C) 10 (7.2 M, respectively) and analyzed by illumination with a hand-held UV lamp. Table S1 Spectral properties of coumarin derivatives 1-10.
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WT-TTR (5) 2

Data Collection
Ramachandran plot
Most favored (%) 99.6 Additionally allowed (%) 0.4
R.M.S deviations
Bond lengths (Å) 0.15 Angles (°,) 1.72
a Numbers in parentheses throughout are for highest resolution sell of data. 
Acid-mediated Fibril Formation Assay with WT-TTR
WT-TTR was expressed and purified from an E. coli expression system as described previously. to evenly distribute any precipitate, the turbidity of the solution at 600 nm was measured using a Thermo Genesis 10S UV-Vis spectrometer.
Binding Stoichiometry of 5 to TTR in Human Blood Plasma.
The plasma TTR binding selectivity assay has been previously described. 2 Briefly, to a 1 mL sample of human blood plasma in a 2 mL Eppendorf tube was added 5 (7.5 L of a 1.44 mM solution in DMSO, final concentration: 10.8 M) and then the plasma solution was incubated at 37 °C for 24 h on a rocker plate (30 rpm). A 1:1 (v/v) slurry of unfunctionalized sepharose resin in TSA buffer (10 mM Tris, 140 mM NaCl, pH 8.0) was added and the solution was incubated for 1 h at 4 °C on a rocker plate (18 rpm). The solution was then centrifuged and the supernatant was divided into two 400 L aliquots, which were added to 200 L of 1:1 (v:v) slurry of anti-TTR antibody conjugated sepharose resin in TSA. The solution was gently rocked (18 rpm) at 4 °C for 20 min, then centrifuged and the supernatant removed. The resin was washed three times by shaking for 1 min with 1 mL of TSA containing 0.05% saponin and then twice more with 1 mL of TSA. After centrifugation to remove the supernatant, 155 L of triethylamine (100 mM, pH 11.5) was added to the sepharose resin to dissociate the TTR and bound test compound from the resin and the suspension was vortexed for 1 min. After centrifugation, the supernatant was analyzed by reverse phase HPLC on a Waters 600 E multi-solvent delivery system, using a Waters 486 tunable absorbance detector, a 717 autosampler, and a ThermoHypersil Keystone
Betabasic-18 column (150 Å pore size, 3 m particle size). The "A" mobile phase comprises 0.1% Urea-mediated TTR Dissociation Study. TTR (0.4 mg/mL) was incubated with increasing concentrations of urea in 10 mM sodium phosphate buffer, 100 mM KCl and 1 mM EDTA (pH 7.0). The mixtures were vortexed and incubated in the dark at 25 °C without agitation.
Compound 5 was added to TTR-urea solution just before the fluorescence measurement.
Crystallization and Structure Determination of the WT-TTR(5) 2 . Wild type TTR protein was concentrated to 6 mg/mL in 10 mM sodium phosphate buffer and 100 mM KCl (pH 7.6) and co-crystallized at room temperature with a 5 molar excess of 5 using the vapor-diffusion sitting drop method. The crystals were grown from 1.395 M sodium citrate, 3.5% v/v glycerol at pH 5.5
and cryo-protected with 10% v/v glycerol. Data were collected at beam-lines 11-1 at the Stanford Synchrotron Radiation Lightsource (SSRL) at a wavelength of 0.9795 Å. Diffraction data were indexed, integrated, and scaled using XDS in space group P2 1 2 1 2 with two subunits observed per asymmetric unit. The structure was determined by molecular replacement using the model coordinates of 2FBR 3 in the program Phaser 4 . Ligand coordinates and restraints files were generated using the PRODRG server (http://davapc1.bioch.dundee.ac.uk/prodrg/). Ligands were assigned an occupancy of 0.5 to account for their position on the incident 2-fold symmetry axis (z-or C2). Further model building and refinement was completed using Coot 5 and Refmac5models were validated using the JCSG quality control server incorporating Molprobity 6 , ADIT Table S2 .
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General synthetic method Unless otherwise indicated, all reactions were run under nitrogen gas.
The progress of the reactions was monitored by TLC. All products were determined by 1 
3-bromo-6-methoxy-4-methyl-2H-chromen-2-one (14). Compound 14 was prepared
according to the representative procedure for bromination from compound 11. The residue was subjected to column chromatography over silica gel (Hexane/EtOAc = 5:1) to give 14 (437 mg, 66% 
0.5 mmol) in degassed 1, 4-dioxane (9 mL), tributyl(vinyl) tin (1.1 mL, 3.4 mmol) was added.
The solution was stirred and refluxed for 10 h. The mixture was filtered through Celite pad. The filtrate was diluted with EtOAc. The organic layer was washed with 10% KI and saturated brine. 
(E)-3-(4-((2-methoxyethoxy)methoxy)-3,5-dimethylstyryl)-4-methyl-2H-chromen-2-one (20).
Compound 20 was prepared according to the general procedure for Heck reaction from 13
and 17. The residue was subjected to column chromatography over silica gel (Hexane/EtOAc = 
(E)-6-methoxy-3-(4-((2-methoxyethoxy)methoxy)-3,5-dimethylstyryl)-4-methyl-2H-
chromen-2-one (21
3-((4-((2-methoxyethoxy)methoxy)-3,5-dimethylphenyl)ethynyl)-4-methyl-2H-chromen-2-one (23).
Compound 23 was prepared according to the general procedure for Sonogashira reaction from 13 and 19. The residue was subjected to column chromatography over silica gel 
7-methoxy-3-((4-((2-methoxyethoxy)methoxy)-3,5-dimethylphenyl)-ethynyl)-4-methyl-2H-chromen-2-one (25).
Compound 25 was prepared according to the general procedure for Sonogashira reaction from 15 and 19. The residue was subjected to column chromatography over silica gel (Hexane/EtOAc = 2:1) to give 25 (72 mg, 46 % 
General
(E)-3-(4-hydroxy-3,5-dimethylstyryl)-7-methoxy-4-methyl-2H-chromen-2-one (3).
Compound 3 was prepared according to the general procedure for MEM deprotection reaction from compound 22. The residue was subjected to column chromatography over silica gel (Hexane/EtOAc = 3:1) to give 3 (26 mg, 28 % Purity: 97 %.
(E)-3-(4-hydroxy-3,5-dimethylstyryl)-7-methoxy-4-methyl-2H-chromen-2-one (7).
Compound 7 was prepared according to the general procedure for MEM deprotection reaction from compound 24. The residue was subjected to column chromatography over silica gel (Hexane/EtOAc = 2:1) to give 7 (107 mg, 99 % (E)-7-hydroxy-3-(4-hydroxy-3,5-dimethylstyryl)-4-methyl-2H-chromen-2-one (5).
Compound 5 was prepared according to the general procedure for demethylation from compound 3 (36% 
6-hydroxy-3-((4-hydroxy-3,5-dimethylphenyl)ethynyl)-4-methyl-2H-chromen-2-one (9).
Compound 9 was prepared according to the general procedure for demethylation from compound 7-hydroxy-3-((4-hydroxy-3,5-dimethylphenyl)ethynyl)-4-methyl-2H-chromen-2-one (10).
Compound 10 was prepared according to the general procedure for demethylation from compound 8 (39 % 
